benzimidazole has been researched along with Protein Aggregation, Pathological in 1 studies
1H-benzimidazole : The 1H-tautomer of benzimidazole.
Protein Aggregation, Pathological: A biochemical phenomenon in which misfolded proteins aggregate either intra- or extracellularly. Triggered by factors such as MUTATION; POST-TRANSLATIONAL MODIFICATIONS, and environmental stress, it is generally associated with ALZHEIMER DISEASE; PARKINSON DISEASE; HUNTINGTON DISEASE; and TYPE 2 DIABETES MELLITUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, YB | 1 |
| Tao, C | 1 |
| Tan, CP | 1 |
| Zhao, P | 1 |
1 other study available for benzimidazole and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Inhibition of Aβ peptide aggregation by ruthenium(II) polypyridyl complexes through copper chelation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzimidazoles; Cell Line, Tumor; Cell Survival; Chelating | 2021 |